Published in Cell on June 26, 2009
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature (2010) 3.52
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc Natl Acad Sci U S A (2010) 2.85
The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer (2012) 2.79
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc Natl Acad Sci U S A (2009) 2.55
Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell (2013) 2.49
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol Cell (2011) 2.35
Architecture and membrane interactions of the EGF receptor. Cell (2013) 2.29
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell (2013) 2.28
Phosphorylation-dependent differential regulation of plant growth, cell death, and innate immunity by the regulatory receptor-like kinase BAK1. PLoS Genet (2011) 2.13
Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol (2010) 1.90
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res (2012) 1.87
Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell (2010) 1.79
Pseudokinases-remnants of evolution or key allosteric regulators? Curr Opin Struct Biol (2010) 1.76
How IGF-1 activates its receptor. Elife (2014) 1.74
The FRET signatures of noninteracting proteins in membranes: simulations and experiments. Biophys J (2014) 1.73
HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy. Clin Cancer Res (2010) 1.73
EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res (2011) 1.66
Regulation of human EGF receptor by lipids. Proc Natl Acad Sci U S A (2011) 1.64
Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Res (2011) 1.64
Retracted An ATP-competitive inhibitor modulates the allosteric function of the HER3 pseudokinase. Chem Biol (2014) 1.54
EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget (2010) 1.53
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations. Sci Signal (2014) 1.49
Roles for growth factors in cancer progression. Physiology (Bethesda) (2010) 1.48
Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc Natl Acad Sci U S A (2010) 1.45
Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat Struct Mol Biol (2011) 1.45
Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer (2012) 1.44
Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region. Chem Biol (2015) 1.43
The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb Perspect Biol (2014) 1.39
Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. J Biol Chem (2009) 1.36
Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer. Biochim Biophys Acta (2009) 1.35
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism. Oncogene (2010) 1.30
Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy. FEBS Lett (2010) 1.30
Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol (2014) 1.29
Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc Natl Acad Sci U S A (2011) 1.27
Regulation of the catalytic activity of the EGF receptor. Curr Opin Struct Biol (2011) 1.26
Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure (2009) 1.25
Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb Perspect Biol (2014) 1.23
The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization. Sci Signal (2010) 1.22
Mechanistic insights into the activation of oncogenic forms of EGF receptor. Nat Struct Mol Biol (2011) 1.21
Insights into EB1 structure and the role of its C-terminal domain for discriminating microtubule tips from the lattice. Mol Biol Cell (2011) 1.19
Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation. ACS Chem Biol (2012) 1.18
Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes. Angew Chem Int Ed Engl (2015) 1.17
Ligand-induced EGF receptor oligomerization is kinase-dependent and enhances internalization. J Biol Chem (2010) 1.11
EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization. PLoS One (2011) 1.07
Physical-chemical principles underlying RTK activation, and their implications for human disease. Biochim Biophys Acta (2011) 1.06
Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors. Mol Cancer Ther (2012) 1.06
Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics. Cell Adh Migr (2010) 1.06
Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases. PLoS Comput Biol (2011) 1.06
Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis. Dev Cell (2012) 1.04
Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation. Pflugers Arch (2010) 1.04
A structural perspective on the regulation of the epidermal growth factor receptor. Annu Rev Biochem (2015) 1.04
Crystal structures of the phosphorylated BRI1 kinase domain and implications for brassinosteroid signal initiation. Plant J (2014) 1.03
Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol (2010) 1.03
Characterization of the CaMKKβ-AMPK signaling complex. Cell Signal (2011) 1.03
Kinase-mediated quasi-dimers of EGFR. FASEB J (2010) 1.01
Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye? Cell Adh Migr (2010) 1.01
Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J Biol Chem (2012) 1.01
Exploring higher-order EGFR oligomerisation and phosphorylation--a combined experimental and theoretical approach. Mol Biosyst (2013) 0.96
Collagen recognition and transmembrane signalling by discoidin domain receptors. Biochim Biophys Acta (2012) 0.96
Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family. Biochem J (2012) 0.95
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem J (2012) 0.95
The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding. J Biol Chem (2011) 0.95
Allosteric communication across the native and mutated KIT receptor tyrosine kinase. PLoS Comput Biol (2012) 0.94
The juxtamembrane region of EGFR takes center stage. Cell (2009) 0.94
Regulation of EGFR nanocluster formation by ionic protein-lipid interaction. Cell Res (2014) 0.93
Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies. Structure (2013) 0.93
Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation. J Biol Chem (2014) 0.93
The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction. J Biol Chem (2010) 0.93
Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides. Proc Natl Acad Sci U S A (2013) 0.92
N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc Natl Acad Sci U S A (2015) 0.91
Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase. Mol Cell Proteomics (2011) 0.91
A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2014) 0.91
Lineage-specific co-evolution of the Egf receptor/ligand signaling system. BMC Evol Biol (2010) 0.90
β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. Mol Biol Cell (2011) 0.90
Yet another "active" pseudokinase, Erb3. Proc Natl Acad Sci U S A (2010) 0.90
Mechanisms of resistance to EGFR targeted therapies. Cancer Biol Ther (2013) 0.90
A view into the blind spot: solution NMR provides new insights into signal transduction across the lipid bilayer. Structure (2010) 0.89
Transmembrane helix-helix interactions involved in ErbB receptor signaling. Cell Adh Migr (2010) 0.89
ANO1 interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Oncotarget (2015) 0.89
Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. Cell Rep (2014) 0.88
A helix heterodimer in a lipid bilayer: prediction of the structure of an integrin transmembrane domain via multiscale simulations. Structure (2011) 0.88
A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network. Mol Biosyst (2011) 0.88
Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: Insights from multiscale molecular dynamics simulations. Biochim Biophys Acta (2014) 0.87
Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J Biol Chem (2013) 0.87
Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling. Biophys J (2013) 0.87
Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor. Mol Cell Biol (2015) 0.87
Temporal resolution of autophosphorylation for normal and oncogenic forms of EGFR and differential effects of gefitinib. Biochemistry (2012) 0.87
Putting together structures of epidermal growth factor receptors. Curr Opin Struct Biol (2014) 0.86
Oligomerization of DHHC protein S-acyltransferases. J Biol Chem (2013) 0.86
HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways. Protein Cell (2012) 0.86
Mechanisms of activation of receptor tyrosine kinases: monomers or dimers. Cells (2014) 0.86
The energy landscape analysis of cancer mutations in protein kinases. PLoS One (2011) 0.86
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling. PLoS One (2011) 0.85
Structure elucidation of dimeric transmembrane domains of bitopic proteins. Cell Adh Migr (2010) 0.85
Molecular basis for multimerization in the activation of the epidermal growth factor receptor. Elife (2016) 0.85
Structural Basis for the Non-catalytic Functions of Protein Kinases. Structure (2016) 0.84
Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence. Sci Rep (2012) 0.84
Reorienting the Fab domains of trastuzumab results in potent HER2 activators. PLoS One (2012) 0.84
Time-resolved fluorescence spectroscopy measures clustering and mobility of a G protein-coupled receptor opsin in live cell membranes. J Am Chem Soc (2014) 0.84
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science (1991) 10.81
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell (2006) 10.28
Crystal structure of the Src family tyrosine kinase Hck. Nature (1997) 7.66
Three-dimensional structure of the tyrosine kinase c-Src. Nature (1997) 7.62
Single-molecule imaging of EGFR signalling on the surface of living cells. Nat Cell Biol (2000) 6.63
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res (2004) 6.53
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med (2005) 6.04
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell (2007) 5.95
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell (2002) 5.64
Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem (2002) 5.63
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell (2002) 5.61
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A (1994) 5.44
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell (2003) 5.06
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res (2000) 4.79
Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature (1984) 4.27
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res (2005) 4.25
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell (2003) 4.23
A helix propensity scale based on experimental studies of peptides and proteins. Biophys J (1998) 3.95
The design of coiled-coil structures and assemblies. Adv Protein Chem (2005) 2.87
Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure (2008) 2.79
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature (2007) 2.78
A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell (2007) 2.70
Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell (2007) 2.68
Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature (1991) 2.60
Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol (2001) 2.50
Interaction of activated EGF receptors with coated pit adaptins. Science (1993) 2.42
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation. Proc Natl Acad Sci U S A (2007) 2.20
Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif. J Biol Chem (1996) 2.10
Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol (2007) 1.96
Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol Biol Cell (2002) 1.95
The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function. Proc Natl Acad Sci U S A (2004) 1.89
A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci U S A (2002) 1.86
Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J Biol Chem (2008) 1.81
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family. J Gen Physiol (2005) 1.64
Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase. Mol Biol Cell (2000) 1.62
Neu receptor dimerization. Nature (1989) 1.58
Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene (1997) 1.52
A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem Biophys Res Commun (1992) 1.35
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases. Proc Natl Acad Sci U S A (2008) 1.33
Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol Cell Biol (1998) 1.30
The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J Biol Chem (1995) 1.25
A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure (2004) 1.24
Predominance of activated EGFR higher-order oligomers on the cell surface. Growth Factors (2008) 1.24
A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor. J Biol Chem (2005) 1.18
Dynamic equilibrium between multiple active and inactive conformations explains regulation and oncogenic mutations in ErbB receptors. Biochim Biophys Acta (2007) 1.10
Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand. Growth Factors (2003) 1.01
Activation of the EGF receptor by insertional mutations in its juxtamembrane regions. Oncogene (1995) 0.98
Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases. Bioorg Med Chem Lett (2008) 0.97
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell (2002) 13.03
The conformational plasticity of protein kinases. Cell (2002) 11.21
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell (2006) 10.28
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Structural analysis of a eukaryotic sliding DNA clamp-clamp loader complex. Nature (2004) 4.37
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res (2002) 4.19
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature (2012) 4.01
Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell (2003) 3.66
A myristoyl/phosphotyrosine switch regulates c-Abl. Cell (2003) 3.48
A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol (2006) 3.40
Activation of tyrosine kinases by mutation of the gatekeeper threonine. Nat Struct Mol Biol (2008) 3.18
Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science (2006) 3.15
Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell (2005) 3.08
Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell (2013) 2.97
Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Biol (2008) 2.82
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature (2007) 2.78
Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell (2007) 2.68
Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell (2012) 2.67
The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell (2011) 2.58
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc Natl Acad Sci U S A (2009) 2.55
Regulation of the transcriptional activator NtrC1: structural studies of the regulatory and AAA+ ATPase domains. Genes Dev (2003) 2.50
Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell (2013) 2.49
Structure of a sliding clamp on DNA. Cell (2008) 2.42
Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases. Proc Natl Acad Sci U S A (2004) 2.41
Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell (2004) 2.38
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol Cell (2011) 2.35
High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. Protein Sci (2005) 2.32
Mechanism of transport of IFT particles in C. elegans cilia by the concerted action of kinesin-II and OSM-3 motors. J Cell Biol (2006) 2.32
Architecture and membrane interactions of the EGF receptor. Cell (2013) 2.29
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell (2006) 2.28
A conserved protonation-dependent switch controls drug binding in the Abl kinase. Proc Natl Acad Sci U S A (2008) 2.18
The structure, regulation, and function of ZAP-70. Immunol Rev (2009) 2.01
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680. Cancer Res (2006) 1.98
Crystal structure of a tetradecameric assembly of the association domain of Ca2+/calmodulin-dependent kinase II. Mol Cell (2003) 1.98
Crystal structure of the catalytic alpha subunit of E. coli replicative DNA polymerase III. Cell (2006) 1.94
c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. Structure (2007) 1.87
Molecular mechanisms in signal transduction at the membrane. Nat Struct Mol Biol (2010) 1.86
Clamp loaders and sliding clamps. Curr Opin Struct Biol (2002) 1.77
Motors and switches: AAA+ machines within the replisome. Nat Rev Mol Cell Biol (2002) 1.74
Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases. Sci Signal (2013) 1.73
The mechanism of ATP-dependent primer-template recognition by a clamp loader complex. Cell (2009) 1.72
Regulation of ras signaling dynamics by Sos-mediated positive feedback. Curr Biol (2006) 1.70
ATP ground- and transition states of bacterial enhancer binding AAA+ ATPases support complex formation with their target protein, sigma54. Structure (2007) 1.69
Structural basis for the recognition of c-Src by its inactivator Csk. Cell (2008) 1.66
Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations. Cancer Res (2009) 1.64
Structures of Escherichia coli DNA mismatch repair enzyme MutS in complex with different mismatches: a common recognition mode for diverse substrates. Nucleic Acids Res (2003) 1.62
Autoinhibition regulates the motility of the C. elegans intraflagellar transport motor OSM-3. J Cell Biol (2006) 1.61
A Ras-induced conformational switch in the Ras activator Son of sevenless. Proc Natl Acad Sci U S A (2006) 1.57
A mechanism for tunable autoinhibition in the structure of a human Ca2+/calmodulin- dependent kinase II holoenzyme. Cell (2011) 1.56
Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife (2014) 1.56
How a DNA polymerase clamp loader opens a sliding clamp. Science (2011) 1.56
Structural characterization of the reaction pathway in phosphoserine phosphatase: crystallographic "snapshots" of intermediate states. J Mol Biol (2002) 1.54
Protein-protein interactions in the allosteric regulation of protein kinases. Curr Opin Struct Biol (2006) 1.49
Structure and dynamics of the Abeta(21-30) peptide from the interplay of NMR experiments and molecular simulations. J Am Chem Soc (2008) 1.47
Probing the function of heme distortion in the H-NOX family. ACS Chem Biol (2008) 1.42
Oligomerization states of the association domain and the holoenyzme of Ca2+/CaM kinase II. FEBS J (2006) 1.40
High-resolution solution structure of the beryllofluoride-activated NtrC receiver domain. Biochemistry (2003) 1.39
A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases. J Mol Biol (2006) 1.39
A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci (2003) 1.39
Negative regulation of AAA + ATPase assembly by two component receiver domains: a transcription activation mechanism that is conserved in mesophilic and extremely hyperthermophilic bacteria. J Mol Biol (2005) 1.39
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Res (2002) 1.34
The NMR solution structure of BeF(3)(-)-activated Spo0F reveals the conformational switch in a phosphorelay system. J Mol Biol (2003) 1.32
Mechanism of proliferating cell nuclear antigen clamp opening by replication factor C. J Biol Chem (2006) 1.32
DNA polymerase clamp loaders and DNA recognition. FEBS Lett (2005) 1.28
Out-of-plane motions in open sliding clamps: molecular dynamics simulations of eukaryotic and archaeal proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (2005) 1.27
The Rut pathway for pyrimidine degradation: novel chemistry and toxicity problems. J Bacteriol (2010) 1.26
Detection and characterization of xenon-binding sites in proteins by 129Xe NMR spectroscopy. J Mol Biol (2002) 1.26
Regulation of the catalytic activity of the EGF receptor. Curr Opin Struct Biol (2011) 1.26
The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase. BMC Struct Biol (2008) 1.26
Clamp loaders and replication initiation. Curr Opin Struct Biol (2006) 1.25
Analysis of the role of PCNA-DNA contacts during clamp loading. BMC Struct Biol (2010) 1.25
Efforts toward expansion of the genetic alphabet: structure and replication of unnatural base pairs. J Am Chem Soc (2007) 1.25
Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J Am Chem Soc (2007) 1.23
Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci Signal (2012) 1.23
The replication factor C clamp loader requires arginine finger sensors to drive DNA binding and proliferating cell nuclear antigen loading. J Biol Chem (2006) 1.22
A structural basis for H-NOX signaling in Shewanella oneidensis by trapping a histidine kinase inhibitory conformation. Proc Natl Acad Sci U S A (2009) 1.22
Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless. Proc Natl Acad Sci U S A (2010) 1.22
Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1. Elife (2013) 1.22
Structure and regulatory mechanism of Aquifex aeolicus NtrC4: variability and evolution in bacterial transcriptional regulation. J Mol Biol (2008) 1.22
Shewanella oneidensis MR-1 fluxome under various oxygen conditions. Appl Environ Microbiol (2006) 1.22